SkinBioTherapeutics PLC (AIM:SBTX), the AIM-listed life sciences company focused on skin health, has completed its latest fundraise, generating approximately £4.2 million in total.
The company announced on Friday that the recently closed WRAP Retail Offer raised around £100,000 by issuing just over 587,000 new shares at 17p each.
This follows the broader placing and subscription rounds, which contributed the majority of the funds by issuing more than 24 million shares at the same price.
The fresh capital will support SkinBioTherapeutics as it continues to develop its pipeline of skin health treatments.